☆ 4.6 Article

Establishment of an Intradermal Canine IL-31-Induced Pruritus Model to Evaluate Therapeutic Candidates in Atopic Dermatitis

VETERINARY SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Editorial Material Allergy

What can we learn from treating atopic itch in dogs?

Angelina Labib et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Add to Collection

Article Pharmacology & Pharmacy

Speed of onset of a new chewable formulation of oclacitinib maleate (Apoquel (R)) in a canine model of IL-31-induced pruritus

Timothy Fleck et al.

Summary: This study aimed to determine if a flavored chewable formulation of oclacitinib provides a similar onset of anti-pruritic activity as the original film-coated tablets. The results showed that the new chewable formulation effectively reduced IL-31-induced pruritus in dogs within 1-3 hours, comparable to the film-coated tablets.

JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2022)

Add to Collection

Review Allergy

Peripheral itch sensitization in atopic dermatitis

Mitsutoshi Tominaga et al.

Summary: Atopic dermatitis is a skin disorder characterized by dryness and dysfunction of the skin barrier, leading to inflammation and chronic itch. The itch sensation is sensitized by the increase in intraepidermal nerve fibers and the secretion of IL-33 by keratinocytes. The breakdown of the skin barrier allows allergens to enter the epidermis, triggering type 2 inflammatory responses and worsening itch. Controlling itch is crucial for the treatment of atopic dermatitis.

ALLERGOLOGY INTERNATIONAL (2022)

Add to Collection

Article Pharmacology & Pharmacy

Nemolizumab: First Approval

Susan J. Keam

Summary: Nemolizumab is a subcutaneously administered drug developed for the treatment of various skin diseases. It effectively alleviates symptoms such as itchiness and inflammation by targeting the neuroimmune cytokine IL-31. The drug has received approval in Japan and can be used for treating itch associated with atopic dermatitis in both adults and children over the age of 13.

DRUGS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

IL-31: State of the Art for an Inflammation-Oriented Interleukin

Francesco Borgia et al.

Summary: This research examines the role of interleukin 31 in various diseases, including skin conditions, allergic pathologies, and hematological disorders. It demonstrates that interleukin 31 is crucial in the pathogenesis, prognosis, and itch severity of these conditions. Monoclonal antibodies targeting interleukin 31 have shown promising efficacy and safety, offering a new approach to therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Allergy

Interleukin-31: The itchy cytokine in inflammation and therapy

Angeliki Datsi et al.

Summary: Interleukin-31 (IL-31) plays a critical role in various atopic disorders, particularly in atopic dermatitis (AD), by modulating inflammatory responses, stimulating itch, and promoting neuronal outgrowth through the IL-31 receptor A/Oncostatin M receptor (IL31RA/OSMR beta) axis. Inhibition of IL-31 downstream signaling shows promise for future therapies targeting inflammatory, neuroinflammatory, and pruritic disorders.

ALLERGY (2021)

Add to Collection

Article Dermatology

Onset and duration of action of lokivetmab in a canine model of IL-31 induced pruritus

Timothy J. Fleck et al.

Summary: The study evaluated the onset of action and duration of effect of lokivetmab in a model of IL-31-induced pruritus in dogs. Results showed that a single subcutaneous injection of 2 mg/kg lokivetmab significantly suppressed pruritus starting 3 hours post-treatment and the effect could be sustained for 42 days.

VETERINARY DERMATOLOGY (2021)

Add to Collection

Article Dermatology

Characterization of a chloroquine-induced canine model of pruritus and skin inflammation

Amanda Blubaugh et al.

VETERINARY DERMATOLOGY (2020)

Add to Collection

Review Dermatology

The Challenge of Basic Itch Research

Earl Carstens et al.

ACTA DERMATO-VENEREOLOGICA (2020)

Add to Collection

Review Dermatology

The Itch-Scratch Cycle: A Review of the Mechanisms

Giulia Rinaldi

DERMATOLOGY PRACTICAL & CONCEPTUAL (2019)

Add to Collection

Article Pharmacology & Pharmacy

Involvement of thromboxane A2 in interleukin-31-induced itch-associated response in mice

Tsugunobu Andoh et al.

PHARMACOLOGICAL REPORTS (2018)

Add to Collection

Article Dermatology

Interleukin (IL) 31 induces in cynomolgus monkeys a rapid and intense itch response that can be inhibited by an IL-31 neutralizing antibody

K. E. Lewis et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)

Add to Collection

Article Dermatology

Involvement of Leukotriene B-4 Released from Keratinocytes in Itch-associated Response to Intradermal Interleukin-31 in Mice

Tsugunobu Andoh et al.

ACTA DERMATO-VENEREOLOGICA (2017)

Add to Collection

Article Dermatology

IL-31-induced pruritus in dogs: a novel experimental model to evaluate anti-pruritic effects of canine therapeutics

Andrea J. Gonzales et al.

VETERINARY DERMATOLOGY (2016)

Add to Collection

Article Allergy

Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge

T. Hawro et al.

ALLERGY (2014)

Add to Collection

Article Allergy

A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1

Ferda Cevikbas et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Add to Collection

Article Dermatology

A single dose of interleukin-31 (IL-31) causes continuous itch-associated scratching behaviour in mice

Iwao Arai et al.

EXPERIMENTAL DERMATOLOGY (2013)

Add to Collection

Article Dermatology

Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis

Andrea J. Gonzales et al.

VETERINARY DERMATOLOGY (2013)

Add to Collection

Article Dermatology

Characterization of pruritus in canine atopic dermatitis, flea bite hypersensitivity and flea infestation and its role in diagnosis

Vincent Bruet et al.

VETERINARY DERMATOLOGY (2012)

Add to Collection

Article Dermatology

Quality of life of dogs with skin diseases and their owners. Part 1: development and validation of a questionnaire

Chiara Noli et al.

VETERINARY DERMATOLOGY (2011)

Add to Collection

Article Dermatology

Differential Itch- and Pain-related Behavioral Responses and mu-opioid Modulation in Mice

Tasuku Akiyama et al.

ACTA DERMATO-VENEREOLOGICA (2010)

Add to Collection

Article Dermatology

Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis

Thierry Olivry et al.

VETERINARY DERMATOLOGY (2010)

Add to Collection

Review Biochemistry & Molecular Biology

Structures and biological functions of IL-31 and IL-31 receptors

Qing Zhang et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.